翔宇医疗
(688626)
| 流通市值：88.32亿 | | | 总市值：88.32亿 |
| 流通股本：1.60亿 | | | 总股本：1.60亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 748,081,490.03 | 770,840,604.44 | 743,181,202.45 | 732,040,421.44 |
| 交易性金融资产 | 100,945,095.91 | 100,386,630.15 | - | - |
| 应收票据及应收账款 | 63,159,719.22 | 70,332,888.28 | 64,783,864.53 | 56,825,531.77 |
| 其中：应收票据 | 71,331.06 | 400,000 | - | - |
| 应收账款 | 63,088,388.16 | 69,932,888.28 | 64,783,864.53 | 56,825,531.77 |
| 应收款项融资 | 336,192.3 | 1,187,017.3 | 282,350 | 270,705 |
| 预付款项 | 26,846,772.14 | 32,497,927.34 | 28,763,110.62 | 42,549,812.91 |
| 其他应收款合计 | 14,406,817.08 | 16,051,091.53 | 15,244,821.32 | 12,057,868.38 |
| 存货 | 266,041,206.01 | 256,662,650.55 | 238,206,721.64 | 240,905,036.2 |
| 合同资产 | 2,628,108.95 | 2,729,837.15 | 2,636,408.77 | 2,827,250.62 |
| 其他流动资产 | 67,016,727.06 | 53,881,283.63 | 48,616,717.73 | 44,432,571.58 |
| 流动资产合计 | 1,289,462,128.7 | 1,304,569,930.37 | 1,141,715,197.06 | 1,131,909,197.9 |
| 非流动资产: | | | | |
| 长期应收款 | 27,633,383.93 | 29,095,079.8 | 33,079,688.62 | 38,829,919.83 |
| 长期股权投资 | 13,244,789.53 | 13,293,975.3 | 13,373,899.15 | 13,203,275.39 |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 固定资产 | 951,513,793.18 | 935,726,319.55 | 952,370,592.43 | 509,307,243.89 |
| 在建工程 | 376,620,314.37 | 296,737,886.02 | 252,266,810.25 | 589,071,162.31 |
| 使用权资产 | 10,473,464.58 | 11,149,860.81 | 11,816,643.88 | 5,379,884.45 |
| 无形资产 | 213,221,041.34 | 215,159,872.26 | 216,886,251.78 | 215,704,269.23 |
| 开发支出 | 6,915,473.84 | - | - | - |
| 长期待摊费用 | 17,867,665.87 | 17,424,519.91 | 16,566,332.68 | 7,158,126.15 |
| 递延所得税资产 | 7,505,721.01 | 7,850,329.87 | 9,553,900.6 | 6,539,455.36 |
| 其他非流动资产 | 291,698,069.14 | 265,927,818.38 | 270,245,022.36 | 275,627,821.79 |
| 非流动资产合计 | 1,926,693,716.79 | 1,802,365,661.9 | 1,786,159,141.75 | 1,670,821,158.4 |
| 资产总计 | 3,216,155,845.49 | 3,106,935,592.27 | 2,927,874,338.81 | 2,802,730,356.3 |
| 流动负债: | | | | |
| 短期借款 | 616,090,000 | 580,196,561.1 | 354,096,561.1 | 329,990,000 |
| 应付票据及应付账款 | 180,808,127.25 | 91,098,404.49 | 135,811,914.7 | 82,239,116.82 |
| 其中：应付票据 | - | 2,049,596.73 | 1,670,175.52 | 1,690,435.35 |
| 应付账款 | 180,808,127.25 | 89,048,807.76 | 134,141,739.18 | 80,548,681.47 |
| 合同负债 | 149,189,784.66 | 137,846,507.88 | 127,973,780.8 | 112,029,890.55 |
| 应付职工薪酬 | 30,390,081.85 | 28,062,886.17 | 28,479,482.07 | 25,549,527.09 |
| 应交税费 | 6,075,084.64 | 8,966,050.44 | 15,689,575.48 | 10,692,194.12 |
| 其他应付款合计 | 49,144,628.09 | 54,859,203.2 | 54,624,683.52 | 48,031,983.55 |
| 一年内到期的非流动负债 | 1,206,605.75 | 509,287.82 | 1,120,329.02 | - |
| 其他流动负债 | 19,668,999.7 | 17,601,716.91 | 16,915,294.34 | 15,435,993.87 |
| 流动负债合计 | 1,052,573,311.94 | 919,140,618.01 | 734,711,621.03 | 623,968,706 |
| 非流动负债: | | | | |
| 租赁负债 | 10,315,074.32 | 11,126,548.11 | 11,136,639.58 | 5,418,076.47 |
| 递延收益 | 130,333,760.98 | 127,860,092.87 | 127,248,541.76 | 131,442,924.65 |
| 非流动负债合计 | 140,648,835.3 | 138,986,640.98 | 138,385,181.34 | 136,861,001.12 |
| 负债合计 | 1,193,222,147.24 | 1,058,127,258.99 | 873,096,802.37 | 760,829,707.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 1,296,125,138.94 | 1,296,125,138.94 | 1,299,138,880.31 | 1,299,419,079.37 |
| 减:库存股 | 201,831,428.45 | 201,831,428.45 | 176,503,844.96 | 160,308,381.43 |
| 盈余公积 | 80,000,000 | 80,000,000 | 80,000,000 | 80,000,000 |
| 未分配利润 | 674,454,067.21 | 698,995,112.37 | 676,044,098.77 | 646,514,480.03 |
| 归属于母公司股东权益合计 | 2,008,747,777.7 | 2,033,288,822.86 | 2,038,679,134.12 | 2,025,625,177.97 |
| 少数股东权益 | 14,185,920.55 | 15,519,510.42 | 16,098,402.32 | 16,275,471.21 |
| 股东权益合计 | 2,022,933,698.25 | 2,048,808,333.28 | 2,054,777,536.44 | 2,041,900,649.18 |
| 负债和股东权益合计 | 3,216,155,845.49 | 3,106,935,592.27 | 2,927,874,338.81 | 2,802,730,356.3 |
| 公告日期 | 2025-08-29 | 2025-04-25 | 2025-04-25 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |